FLT3 inhibitor KRN383 on xenografted human leukemic cells harboring FLT3-activating mutations: FLT3 in AML: Much more to learn about biology and optimal targeting
Francis J. GilesVolume:
30
Year:
2006
Language:
english
Pages:
2
DOI:
10.1016/j.leukres.2006.03.002
File:
PDF, 84 KB
english, 2006